Molecular Heterogeneity of Diffuse Large B-cell Lymphoma: Implications for Disease Management and Prognosis

References

• Harris, N.L., Jaffe, E.S., Stein, H., Banks, P.M., Chan, J.C.K., Cleary, M.L., Delsol, G., De Wolf-Peeters, C., Falini, B., Gatter, Kc., Groan, T.M., Isaacson, P.C., Knowles, D.M., Mason, D.Y., Miiller-Hermelink, H.K., Pileri, S.A., Pins, M.A., Ralfkiaer, E. and Warnke, R.A. (1994) "A revised European—American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group", Blood 84, 1361–1392.
   PubMed Web of Science ®Google Scholar
• Jaffe, ES., Harris, N.L., Stein, H. and Vardiman, J.W. (2001) World Health Organization Classification of Tumors. Pathology and Genetics of Tumors of Haematopoietic and Lymphoid Tissues (IARC Press, Lyon).
   Google Scholar
• Dalla Favera, R. and Gaidano, G. (1998) "The biology of high grade non-Hodgkin lymphomas", In: Cannellos, GE, Lister, T.A. and Sklar, J.L., eds, The Lymphomas (W.B. Saunders Company, Philadelphia), pp. 353–367.
   Google Scholar
• Dalla Favera, R. and Gaidano, G. (2000) "Pathobiology of non-Hodgkin lymphomas", In: Hoffman, R., Benz, E.J., Shattil, S.J., Furie, B., Choen, H.J., Silberstein, L.E. and McGlave, E, eds, Hematology. Basic Principle and Practice, 3rd Ed. (Churchill Linvingstone, Philadelphia), pp. 1213–1229.
   Google Scholar
• Dalla Favera, R. and Gaidano, G. (2001) "Molecular biology of Lymphomas", In: De Vita, V.T., Hellman, S. and Rosenberg, S.A., eds, Cancer. Principles and Practice of Oncology, 6th Ed. (Lippincott Williams, Philadelphia), pp. 2215–2235.
   Google Scholar
• Offit, K., Wong, G., Filippa, D.A., Tao, Y. and Chaganti, R.S. (1991) "Cytogenetic analysis of 434 consecutively ascer-tained specimens of non-Hodgkin's lymphoma: clinical correlations", Blood 77, 1508–1515.
   PubMed Web of Science ®Google Scholar
• Gamberi, B., Gaidano, G., Parsa, N., Carbone, A., Roncella, S., Knowles, D.M., Louie, D.C., Shibata, D., Chaganti, R.S. and Dalla-Favera, R. (1997) "Microsatellite instability is rare in B-cell non-Hodgkin's lymphomas", Blood 89, 975–979.
   PubMed Web of Science ®Google Scholar
• Miiller-Hermelink, H.K. and Greiner, A. (1998) "Molecular analysis of human immunoglobulin heavy chain variable genes (IgVH) in normal and malignant B cells", Am. J. Pathol. 153, 1341–1346.
   PubMed Web of Science ®Google Scholar
• Shen, H.M., Peters, A., Baron, B., Zhu, X. and Storb, U. (1998) "Mutation of BCL-6 gene in normal B cells by the process of somatic hypermutation of Ig genes", Science 280, 1750–1752.
   PubMed Web of Science ®Google Scholar
• Pasqualucci, L., Migliazza, A., Fracchiolla, N., William, C., Neri, A., Baldini, L., Chaganti, R.S., Klein, U., Kappers, R., Rajewsky, K. and Dalla-Favera, R. (1998) "BCL-6 mutations in normal germinal center B cells: evidence of somatic hypermutation acting outside Ig loci", Proc. Natl. Acad. Sci. USA 95, 11816–11821.
   PubMed Web of Science ®Google Scholar
• Kiippers, R., Klein, U., Hansmann, M.L. and Rajewsky, K. (1999) "Cellular origin of human B-cell lymphomas", N. Engl. J. Med. 341, 1520–1529.
   PubMed Web of Science ®Google Scholar
• Peng, H.Z., Du, M.Q., Koulis, A., Aiello, A., Dogan, A., Pan, L.X. and Isaacson, P.G. (1999) "Nonimmunoglobulin gene hypermutation in germinal center B cells", Blood 93, 2167–2172.
   PubMed Web of Science ®Google Scholar
• Gaidano, G. and Carbone, A. (2000) "MUM1: a step ahead toward the understanding of lymphoma histogenesis", Leukemia 14, 563–566.
   PubMed Web of Science ®Google Scholar
• Harris, N.L., Stein, H., Coupland, S.E., Hummel, M., Dalla Favera, R., Pasqualucci, L. and Chan, W.C. (2001) "New approaches to lymphoma diagnosis", Hematology (Am. Soc. Hematol. Educ. Program), 194–220.
   PubMedGoogle Scholar
• Cattoretti, G., Chang, C.C., Cechova, K., Zhang, J., Ye, B.H., Falini, B., Louie, D.C., Offit, K., Chaganti, R.S. and Dana-Favera, R. (1995) "BCL-6 protein is expressed in germinal center B-cells", Blood 86, 45–53.
   PubMed Web of Science ®Google Scholar
• Sebestyen, A., Berczi, L., Mihalik, R., Paku, S., Matolcsy, A. and Kopper, L. (1999) "Syndecan-1 (CD138) expression in human non-Hodgkin lymphomas", Br. J. Haematol. 104, 412–419.
   PubMed Web of Science ®Google Scholar
• Falini, B., Fizzotti, M., Pucciarini, A., Bigerna, B., Marafioti, T., Gambacorta, M., Pacini, R., Alurmi, C., Natali-Tanci, L., Ugolini, B., Sebastiani, C., Cattoretti, G., Pileri, S., Dana-Favera, R. and Stein, H. (2000) "A monoclonal antibody (MUM1p) detects expression of the MUM1/IRF4 protein in a subset of germinal center B cells, plasma cells, and activated T cells", Blood 95, 2084–2092.
   PubMed Web of Science ®Google Scholar
• Falini, B. and Mason, D.Y. (2002) "Proteins encoded by genes involved in chromosomal alterations in lymphoma and leukemia: clinical value of their detection by immunocyto-chemistry", Blood 99, 409–426.
   PubMed Web of Science ®Google Scholar
• Hsu, F.J. and Levy, R. (1995) "Preferential use of the VI-14 Ig gene family by diffuse large-cell lymphoma", Blood 86, 3072–3082.
   PubMed Web of Science ®Google Scholar
• Migliazza, A., Martinotti, S., Chen, W., Fusco, C., Ye, B.H., Knowles, D.M., Offit, K., Chaganti, R.S. and Dalla-Favera, R. (1995) "Frequent somatic hypermutation of the 5 noncoding region of the BCL6 gene in B-cell lymphoma", Proc. Natl. Acad. Sci. USA 92, 12520–12524.
   PubMed Web of Science ®Google Scholar
• Kiippers, R., Rajewsky, K. and Hansmann, M.L. (1997) "Diffuse large cell lymphomas are derived from mature B cells carrying V region genes with a high load of somatic mutation and evidence of selection for antibody expression", Fur. J. Immunol. 27, 1398–1405.
   Web of Science ®Google Scholar
• Taniguchi, M., Oka, K., Hiasa, A., Yamaguchi, M., Ohno, T., Kita, K. and Shiku, H. (1998) "De novo CD5 + diffuse large B-cell lymphomas express VH genes with somatic mutation", Blood 91, 1145–1151.
   PubMed Web of Science ®Google Scholar
• Ottensmeier, C.H., Thompsett, A.R., Zhu, D., Wilkins, B.S., Sweetenham, J.W. and Stevenson, F.K. (1998) "Analysis of VH genes in follicular and diffuse lymphoma shows ongoing somatic mutation and multiple isotype transcripts in early disease with changes during disease progression", Blood 91, 4292–4299.
   PubMed Web of Science ®Google Scholar
• Harada, S., Suzuki, R., Uehira, K., Yatabe, Y, Kagami, Y., Ogura, M., Suzuki, H., Oyama, A., Kodera, Y, Ueda, R., Morishima, Y, Nakamura, S. and Seto, M. (1999) "Molecular and immunological dissection of diffuse large B cell lymphoma: CD5 +, and CD5— with CD10 + groups may constitute clinically relevant subtypes", Leukemia 13, 1441–1447.
   PubMed Web of Science ®Google Scholar
• Capello, D., Vitolo, U., Pasqualucci, L., Quattrone, S., Migliaretti, G., Fassone, L., Ariatti, C., Vivenza, D., Gloghini, A., Pastore, C., Lanza, C., Nomdedeu, J., Botto, B., Freilone, R., Buonaiuto, D., Zagonel, V, Gallo, E., Palestro, G., Saglio, G., Dalla-Favera, R., Carbone, A. and Gaidano, G. (2000) "Distribution and pattern of BCL-6 mutations throughout the spectrum of B-cell neoplasia", Blood 95, 651–659.
   PubMed Web of Science ®Google Scholar
• Lossos, IS., Okada, C.Y., Tibshirani, R., Warnke, R., Vose, J.M., Greiner, T.C. and Levy, R. (2000) "Molecular analysis of immunoglobulin genes in diffuse large B-cell lymphomas", Blood 95, 1797–1803.
   PubMed Web of Science ®Google Scholar
• Ottensmeier, C.H. and Stevenson, F.K. (2000) "Isotype switch variants reveal clonally related subpopulations in diffuse large B-cell lymphoma", Blood 96, 2550–2556.
   PubMed Web of Science ®Google Scholar
• Nakamura, N., Kuze, T., Hashimoto, Y, Hara, Y, Hoshi, S., Sasaki, Y., Shirakawa, A., Sato, M. and Abe, M. (2001) "Analysis of the immunoglobulin heavy chain gene variable region of CD5-positive and -negative diffuse large B cell lymphoma", Leukemia 15, 452–457.
   PubMed Web of Science ®Google Scholar
• Gaidano, G., Carbone, A., Pastore, C., Capello, D., Migliazza, A., Gloghini, A., Roncella, S., Ferrarini, M., Saglio, G. and Dalla-Favera, R. (1997) "Frequent mutation of the 5' noncoding region of the BCL-6 gene in acquired immuno-deficiency syndrome-related non-Hodgkin's lymphomas", Blood 89, 3755–3762.
   PubMed Web of Science ®Google Scholar
• Gaidano, G., Carbone, A. and Dalla-Favera, R. (1998) "Pathogenesis of AIDS-related lymphomas: molecular and histogenetic heterogeneity", Am. J. Pathol. 152, 623–630.
   PubMed Web of Science ®Google Scholar
• Gaidano, G., Capello, D., Gloghini, A., Pastore, C., Migliazza, A., Quattrone, S., Savinelli, E, Buonaiuto, D., Cilia, A.M., Perin, T., Pasqualucci, L., Canzonieri, V, Saglio, G., Dalla-Favera, R. and Carbone, A. (1998) "BCL-6 in AIDS-related lymphomas: pathogenetic and histogenetic impli-cations", Leuk. Lymphoma 31, 39–46.
   PubMed Web of Science ®Google Scholar
• Gaidano, G., Capello, D. and Carbone, A. (2000) "The molecular basis of acquired immunodeficiency syndrome-related lymphomagenesis", Semin. Oncol. 27, 431–441.
   PubMed Web of Science ®Google Scholar
• Carbone, A., Gloghini, A., Capello, D. and Gaidano, G. (2001) "Genetic pathways and histogenetic models of AIDS-related lymphomas", Fur. J. Cancer 37, 1270–1275.
   Web of Science ®Google Scholar
• Carbone, A., Gaidano, G., Gloghini, A., Pastore, C., Saglio, G., Tirelli, U., Dalla-Favera, R. and Falini, B. (1997) "BCL-6 protein expression in AIDS-related non-Hodgkin's lympho-mas: inverse relationship with Epstein-Barr virus-encoded latent membrane protein-1 expression", Am. J. Pathol. 150, 155–165.
   PubMed Web of Science ®Google Scholar
• Carbone, A., Gaidano, G., Gloghini, A., Larocca, L.M., Capello, D., Canzonieri, V, Antinori, A., Tirelli, U., Mini, B. and Dalla-Favera, R. (1998) "Differential expression of BCL-6, CD138/syndecan-1, and Epstein-Barr virus-encoded latent membrane protein-1 identifies distinct histogenetic subsets of acquired immunodeficiency syndrome-related non-Hodgkin's lymphomas", Blood 91, 747–755.
   PubMed Web of Science ®Google Scholar
• Carbone, A., Gloghini, A., Larocca, L.M., Capello, D., Pierconti, E, Canzonieri, V, Tirelli, U., Dalla-Favera, R. and Gaidano, G. (2001) "Expression profile of MUM1/IRF4, BCL-6, and CD138/syndecan-1 defines novel histogenetic subsets of human immunodeficiency virus-related lympho-mas", Blood 97, 744–751.
   PubMed Web of Science ®Google Scholar
• Cesarman, E., Chadburn, A., Liu, Y.F., Migliazza, A., Dalla-Favera, R. and Knowles, D.M. (1998) "BCL-6 gene mutations in posttransplantation lymphoproliferative disorders pre-dict response to therapy and clinical outcome", Blood 92, 2294–2302.
   PubMed Web of Science ®Google Scholar
• Capello, D., Vivenza, D., Muti, G., Rossi, D., Berra, E., Franceschetti, S., Oreste, P., Viglio, A., Morra, E., Paulli, M. and Gaidano, G. (2001) "Molecular histogenesis of post-transplant lymphoproliferative disorders", Blood 98, 805a.
   PubMed Web of Science ®Google Scholar
• Ariatti, C., Vivenza, D., Capello, D., Migliazza, A., Parvis, G., Fassone, L., Buonaiuto, D., Savinelli, F., Rossi, D., Saglio, G. and Gaidano, G. (2000) "Common-variable immunodefi-ciency-related lymphomas associate with mutations and rearrangements of BCL-6: pathogenetic and histogenetic implications", Hum. Pathol. 31, 871–873.
   PubMed Web of Science ®Google Scholar
• Ariatti, C., Rossi, D., Vivenza, D., Berra, E., Benevolo, G., Fontana, M. and Conconi, A. (2001) "Molecular characteri-zation of common variable immunodeficiency-related lymphomas", Ann. Ital. Med. Int. 16, 163–169.
   PubMedGoogle Scholar
• Vanasse, G.J., Concannon, P. and Willerford, D.M. (1999) "Regulated genomic instability and neoplasia in the lymphoid lineage", Blood 94, 3997–4010.
   PubMed Web of Science ®Google Scholar
• Willis, T.G. and Dyer, M.J. (2000) "The role of immunoglo-bulin translocations in the pathogenesis of B-cell malig-nancies", Blood 96, 808–822.
   PubMed Web of Science ®Google Scholar
• Offit, K., Jhanwar, S., Ebrahim, S., Filippa, D., Clarkson, B.D. and Chaganti, R.S. (1989) "t(3;22)(q27;q11), a novel translo-cation associated with diffuse non-Hodgkin lymphoma", Blood 74, 1876–1879.
   PubMed Web of Science ®Google Scholar
• Bastard, C., Tilly, H., Lenorman, B., Bigorgne, C., Boulet, D., Kunlin, A., Monconduit, M. and Piguet, H. (1992) "Translocations involving band 3q27 and Ig gene regions in non-Hodgkin lymphomas", Blood 79, 2527–2531.
   PubMed Web of Science ®Google Scholar
• Baron, B.W., Nucifora, G., McCabe, N., Espinosa, 3rd, R., Le Beau, M.M. and McKeithan, T.W. (1993) "Identification of the gene associated with the recurring chromosomal translocations t(3;14)(q27;q32) and t(3;22)(q27;q11) in B-cell lymphomas", Proc. Natl. Acad. Sci. USA 90, 5262–5266.
   PubMed Web of Science ®Google Scholar
• Kerckaert, J.P., Deweindt, C., Tilly, H., Quief, S., Lecocq, G. and Bastard, C. (1993) "LAZ3, a novel zinc finger encoding gene, is disrupted by recurring chromosome 3q27 transloca-tions in human lymphoma", Nat. Genet. 5, 66–70.
   PubMed Web of Science ®Google Scholar
• Ye, B.H., Lista, F., Lo Coco, F., Knowles, D.M., Offit, K., Chaganti, R.S. and Dalla-Favera, R. (1993) "Alterations of BCL-6, a novel zinc finger gene, in diffuse large cell lymphoma", Science 262, 747–750.
   PubMed Web of Science ®Google Scholar
• Ye, B.H., Rao, PH., Chaganti, R.S. and Dalla-Favera, R. (1993) "Cloning of BCL-6, the locus involved in chromosome translocations affecting band 3q27 in B-cell lymphoma", Cancer. Res. 53, 2732–2735.
   PubMed Web of Science ®Google Scholar
• Mild, T., Kawamata, N., Arai, A., Ohashi, K., Nakamura, Y., Kato, A., Hirosawa, S. and Aoki, N. (1994) "Molecular cloning of the breakpont for 3q27 translocation in B-cell lymphomas and leukemias", Blood 83, 217–222.
   PubMed Web of Science ®Google Scholar
• Bardwell, V.J. and Treisman, R. (1994) "The POZ domain: a conserved protein—protein interaction motif", Genes. Dev. 8, 1664–1677.
   PubMed Web of Science ®Google Scholar
• Chang, C.C., Ye, B.H., Chaganti, R.S. and Dalla-Favera, R. (1996) "BCL-6, a POZ/zinc finger protein, is a sequence specific transcriptional repressor", Proc. Natl. Acad. Sci. USA 93, 6947–6952.
   PubMed Web of Science ®Google Scholar
• Allman, D., Jain, A., Dent, A., Maile, R.R., Selvaggi, T., Kehry, Ma. and Staudt, L.M. (1996) "BCL-6 expression during B-cell activation", Blood 87, 5257–5268.
   PubMed Web of Science ®Google Scholar
• Dalla-Favera, R., Ye, B.H., Cattoretti, G., Lo Coco, F., Chang, C.C., Zhang, J., Migliazza, A., Cechova, K., Niu, H., Chaganti, S., Chen, W., Louie, D.C., Offit, K. and Chaganti, R.S. (1996) "BCL-6 in diffuse large cell lymphomas", Important Adv. Oncol., 139–148.
   PubMedGoogle Scholar
• Dent, AI., Shaffer, Ai., Yu, X., Allman, D. and Staudt, L.M. (1997) "Control of inflammation cytokine expression and germinal center formation by BCL-6", Science 276, 589–592.
   PubMed Web of Science ®Google Scholar
• Ye, B.H., Cattoretti, G., Shen, Q., Zhang, J., Hawe, N., de Waard, R., Leung, C., Nouri-Shirazi, M., Orazi, A., Chaganti, R.S., Rothman, P., Stall, A.M., Pandolfi, P.P. and Dalla-Favera, R. (1997) "The BCL-6 proto-oncogene controls germinal centre formation and TH2 type inflammation", Nat. Genet. 16, 161–170.
   PubMed Web of Science ®Google Scholar
• Ye, B.H., Chaganti, S., Chang, C.C., Niu, H., Corradini, P., Chaganti, R.S. and Dalla-Favera, R. (1995) "Chromosomal translocations cause deregulated BCL6 expression by promoter substitution in B cell lymphoma", EMBO J. 14, 6209–6217.
   PubMed Web of Science ®Google Scholar
• Chen, W., lida, S., Louie, D.C., Dalla-Favera, R. and Chaganti, R.S. (1998) "Heterologous promoters fused to BCL6 by chromosomal translocations affecting band 3q27 cause its deregulated expression during B-cell differen-tiation", Blood 91, 603–607.
   PubMed Web of Science ®Google Scholar
• Bastard, C., Deweindt, C., Kerckaert, J.P., Lenormand, B., Rossi, A., Pezzella, F., Fruchart, C., Duval, C., Monconduit, M. and Tilly, H. (1994) "LAZ3 rearrangements in non-Hodgkin lymphoma: correlation with histology, immuno-phenptype, karyotype and clinical outcome in 217 patients", Blood 83, 2423–2427.
   PubMed Web of Science ®Google Scholar
• Lo Coco, F., Ye, B.H., Lista, F., Corradini, P., Offit, K., Knowles, D.M., Chaganti, R.S. and Dalla-Favera, R. (1994) "Rearrangenents of BCL-6 gene in diffuse large cell non-Hodgkin lymphoma", Blood 83, 1757–1759.
   PubMed Web of Science ®Google Scholar
• Butler, M.P., Iida, S., Capello, D., Rossi, D., Rao, PH., Nallasivam, P., Louie, D.C., Chaganti, S., Au, T., Gascoyne, RD., Gaidano, G., Chaganti, R.S.K. and Dalla-Favera, R. (2002) "Alternative translocation breakpoint cluster regions' to BCL-6 in B-cell non-Hodgkin Lymphoma", Cancer Res. 62, 4089–4094.
   PubMed Web of Science ®Google Scholar
• Offit, K., Lo Coco, F., Louie, D.C., Parsa, N.Z., Leung, D., Portlock, C., Ye, B.H., Lista, F., Filippa, D.A., Rosenbaum, A., Ladany, M., Jhanwar, S., Dalla-Favera, R. and Chaganti, R.S. (1994) "Rearrangement of the bc1-6 gene as a prognostic marker in diffuse large-cell lymphoma", N. Engl. J. Med. 331, 74–80.
   PubMed Web of Science ®Google Scholar
• Otsuki, T., Yano, T., Clark, H.M., Bastard, C., Kerckaert, J.P., Jaffe, E.S. and Raffeld, M. (1995) "Analysis of LAZ3 (BCL-6) status in B-cell non-Hodgkin's lymphomas: results of rearrangement and gene expression studies and a muta-tional analysis of coding region sequences", Blood 85, 2877–2884.
   PubMed Web of Science ®Google Scholar
• Pescarmona, E., De Sanctis, V, Pistilli, A., Pacchiarotti, A., Martelli, M., Guglielmi, C., Mandelli, F., Baroni, C.D. and Lo Coco, F. (1997) "Pathogenetic and clinical implications of Bc1-6 and Bc1-2 gene configuration in nodal diffuse large B-cell lymphomas", J. Pathol. 183, 281–286.
   PubMed Web of Science ®Google Scholar
• Kramer, M.H., Hermans, J., Wijburg, E., Philippo, K., Geelen, E., van Krieken, J.H., de Jong, D., Maartense, E., Schuuring, E. and Kluin, P.M. (1998) "Clinical relevance of BCL2, BCL6, and MYC rearrangements in diffuse large B-cell lym-phoma", Blood 92, 3152–3162.
   PubMed Web of Science ®Google Scholar
• Vitolo, U., Gaidano, G., Botto, B., Volpe, G., Audisio, E., Bertini, M., Calvi, R., Freilone, R., Novero, D., Orsucci, L., Pastore, C., Capello, D., Parvis, G., Sacco, C., Zagonel, V, Carbone, A., Mazza, U., Palestro, G., Saglio, G. and Resegotti, L. (1998) "Rearrangements of bc1-6, bd-2, c-myc and 6q deletion in B-diffuse large-cell lymphoma: clinical relevance in 71 patients", Ann. Oncol. 9, 55–61.
   PubMed Web of Science ®Google Scholar
• Kawasaki, C., Ohshim, K., Suzumiya, J., Kanda, M., Tsuchiya, T., Tamura, K. and Kikuchi, M. (2001) "Rearrange-ments of bcl-1, bc1-2, bc1-6, and c-myc in diffuse large B-cell lymphomas", Leuk. Lymphoma 42, 1099–1106.
   PubMed Web of Science ®Google Scholar
• Jerkeman, M., Aman, P., Cavallin-Stahl, E., Torlakovic, E., Akerman, M., Mitelman, F. and Fioretos, T. (2002) "Prognostic implications of BCL6 rearrangement in uniformly treated patients with diffuse large B-cell lymphoma—a Nordic Lymphoma Group study", Int. J. Oncol. 20, 161–165.
   PubMed Web of Science ®Google Scholar
• Capello, D., Carbone, A., Pastore, C., Gloghini, A., Saglio, G. and Gaidano, G. (1997) "Point mutations of the BCL-6 gene in Burkitt's lymphoma", Br. J. Haematol. 99, 168–170.
   PubMed Web of Science ®Google Scholar
• Vitolo, U., Botto, B., Capello, D., Vivenza, D., Zagonel, V, Gloghini, A., Novero, D., Parvis, G., Calvi, R., Ariatti, C., Milan, I., Bestini, M., Boccomini, C., Freilone, R., Pregno, P., Orsucci, L., Palestro, G., Saglio, G., Carbone, A., Gallo, E. and Gaidano, G. (2002) "Point mutations of the BCL-6 gene: clinical and prognostic correlation in B-diffuse large cell lymphoma", Leukemia 16, 268–275.
   PubMed Web of Science ®Google Scholar
• Alizadeh, A.A., Eisen, MB., Davis, R.E., Ma, C., Lossos, IS., Rosenwald, A., Boldrick, J.C., Sabet, H., Tran, T., Yu, X., Powell, J.I., Yang, L., Marti, G.E., Moore, T., Hudson, Jr, J., Lu, L., Lewis, D.B., Tibshirani, R., Sherlock, G., Chan, W.C., Greiner, T.C., Weisenburger, D.D., Armitage, J.O., Warnke, R. and Staudt, L.M. (2000) "Distinct types of diffuse large B cell lymphoma identified by gene expression profiling", Nature 403, 503–511.
   PubMed Web of Science ®Google Scholar
• Rosenwald, A., Wright, G., Chan, W.C., Connors, J.M., Campo, E., Fisher, R.I., Gascoyne, RD., Muller-Hermelink, H.K., Smeland, E.B., Giltnane, J.M., Hurt, EM., Zhao, H., Averett, L., Yang, L., Wilson, W.H., Jaffe, ES., Simon, R., Klausner, RD., Powell, J., Duffey, Pi., Longo, DI., Greiner, T.C., Weisenburger, D.D., Sanger, W.C., Dave, B.J., Lynch, J.C., Vose, J., Armitage, J.O., Montserrat, E., Lopez-Guillermo, A., Grogan, TM., Miller, T.P., LeBlanc, M., Ott, G., Kvaloy, S., Delabie, J., Holte, H., Krajci, P., Stokke, T. and Staudt, L.M. (2002) Lymphoma/Leukemia Molecular Profil-ing Project "The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lym-phoma", N. Engl. J. Med. 346, 1937–1947.
   Web of Science ®Google Scholar
• Bakhshi, A., Jensen, J.P., Goldman, P., Wright, J.J., McBride, O.W., Epstein, A.L. and Korsmeyer, S.J. (1985) "Cloning the chromosomal breakpoint of 414;18) of human lymphomas: clustering around JH on chromosome 14 and near a transcriptiona unit on 18", Cell 41, 889–906.
   Web of Science ®Google Scholar
• Tsujimoto, Y, Finger, L.R., Yunis, J., Nowell, P.C. and Croce, CM. (1984) "Cloning of the chromosome breakpoints of neoplastic B-cells with t(14;18) chromosomal translocation", Science 226, 1097–1099.
   PubMed Web of Science ®Google Scholar
• Cleary, M.L. and Sklar, J. (1985) "Nucleotide sequence of a 414;18) chromosomal breakpoint in follicular lymphoma and demonstration of a breakpoint cluster region near a transcriptionally active locus on chromosome 18", Proc. Natl. Acad. Sci. USA 82, 7439–7443.
   PubMed Web of Science ®Google Scholar
• Cleary, M.L., Smith, S.D. and Sklar, J. (1986) "Cloning and structural analysis of cDNAs for BCL-2 and a hybrid BCL-2/immunoglobulin transcript resulting from the t(14;18) translocation", Cell 47, 19–28.
   PubMed Web of Science ®Google Scholar
• Cleary, ML., Galili, N. and Sklar, J. (1986) "Detection of a second 414;18) breakpoint duster region in human follicular lymphomas", J. Exp. Med. 164, 315–320.
   PubMed Web of Science ®Google Scholar
• Volpe, G., Vitolo, U., Carbone, A., Pastore, C., Bertini, M., Botto, B., Audisio, E., Freilone, R., Novero, D., Cappia, S., De Giuli, P., Mazza, U., Resegotti, L., Palestro, G., Saglio, G. and Gaidano, G. (1996) "Molecular heterogeneity of B-lineage diffuse large cell lymphoma", Gene Chromosom. Cancer 16, 21–30.
   PubMed Web of Science ®Google Scholar
• Lo Coco, F., Gaidano, G., Louie, D.C., Offit, K., Chaganti, R.S. and Dalla-Favera, R. (1993) "p53 mutations are associated with histologic transformation of follicular lymphomas", Blood 82, 2289–22895.
   PubMed Web of Science ®Google Scholar
• Rao, EH., Houldsworth, J., Dyomina, K., Parsa, N.Z., Cigudosa, J.C., Louie, D.C., Popplewell, L., Offit, K., Jhanwar, S.C. and Chaganti, R.S. (1998) "Chromosomal and gene amplification in diffuse large B-cell lymphoma", Blood 92, 234–240.
   PubMed Web of Science ®Google Scholar
• Monni, O., Joensuu, H., Franssila, K., Klefstrom, J., Alitalo, K. and Knuutila, S. (1997) "BCL-2 overexpression associated with chromosomal amplification in diffuse large B-cell lymphoma", Blood 90, 1168–1174.
   PubMed Web of Science ®Google Scholar
• Chao, D.T. and Korsmeyer, S.J. (1998) "BCL-2 family: regulators of cell death", Annu. Rev. Immunol. 16, 395–419.
   PubMed Web of Science ®Google Scholar
• Gross, A., McDonnell, J.M. and Korsmeyer, S.J. (1999) "BCL-2 family members and the mitochondria in apopto-sis", Genes Dev. 13, 1899–1911.
   PubMed Web of Science ®Google Scholar
• Jacobson, J.O., Wilkes, B.M., Kwaiatkowski, D.J., Medeiros, L.J., Aisenberg, A.C. and Harris, N.L. (1993) "Bc1-2 rearrangements in de novo diffuse large cell lymphoma. Association with distinctive clinical features", Cancer 72, 231–236.
   PubMed Web of Science ®Google Scholar
• Tang, S.C., Visser, L., Hepperle, B., Hanson, J. and Poppema, S. (1994) "Clinical significance of bc1-2-MBR gene rear-rangement and protein expression in diffuse large-cell non-Hodgkin's lymphoma: an analysis of 83 cases", J. Clin. Oncol. 12, 149–154.
   PubMed Web of Science ®Google Scholar
• Hill, M.E., MacLennan, K.A., Cunningham, D.C., Vaughan Hudson, B., Burke, M., Clarke, P., Di Stefano, F., Anderson, L., Vaughan Hudson, G., Mason, D., Selby, P. and Linch, D.C. (1996) "Prognostic significance of BCL-2 expression and bc1-2 major breakpoint region rearrange-ment in diffuse large cell non-Hodgkin's lymphoma: a British National Lymphoma Investigation Study", Blood 88, 1046–1051.
   PubMed Web of Science ®Google Scholar
• Gascoyne, R.D., Adomat, S.A., Krajewski, S., Krajewska, M., Horsman, D.E., Tolcher, A.W., O'Reilly, SE., Hoskins, P., Coldman, A.J., Reed, J.C. and Connors, J.M. (1997) "Prognostic significance of Bc1-2 protein expression and Bc1-2 gene rearrangement in diffuse aggressive non-Hodgkin's lymphoma", Blood 90, 244–251.
   PubMed Web of Science ®Google Scholar
• Houldsworth, J., Mathew, S., Rao, P.H., Dyomina, K., Louie, D.C., Parsa, N., Offit, K. and Chaganti, R.S. (1996) "REL proto-oncogene is frequently amplified in extranodal diffuse large cell lymphoma", Blood 87, 25–29.
   PubMed Web of Science ®Google Scholar
• Lu, D., Thompson, J.D., Gorski, G.K., Rice, N.R., Mayer, M.G. and Yunis, J.J. (1991) "Alterations at the rel locus in human lymphoma", Oncogene 6, 1235–1241.
   PubMed Web of Science ®Google Scholar
• Kralova, J., Schatzle, J.D., Bargmann, W. and Bose, Jr, H.R. (1994) "Transformation of avian fibroblasts overexpressing the c-REL proto-oncogene and a variant of c-REL lacking 40 c-terminal aminoacids", J. Virol. 68, 2073–2083.
   PubMed Web of Science ®Google Scholar
• Dyomin, V.G., Rao, P.H., Dalla-Favera, R. and Chaganti, R.S. (1997) "BCL-8, a novel gene involved in translocations affecting band 15q11-13 in diffuse large cell lymphoma", Proc. Natl. Acad. Sci. USA 94, 5728–5732.
   PubMed Web of Science ®Google Scholar
• Ladanyi, M., Offit, K., Jhanwar, S.C., Filippa, D.A. and Chaganti, R.S. (1991) "MYC rearrangement and transloca-tions involving band 8q24 in diffuse large cell lymphoma", Blood 77, 1057–1063.
   PubMed Web of Science ®Google Scholar
• Akasaka, T., Akasaka, H., Ueda, C., Yonetani, N., Maesako, Y, Shimizu, A., Yamabe, H., Fukuhara, S., Uchiyama, T. and Ohno, H. (2000) "Molecular and clinical features of non-Burkitt's diffuse large cell lymphoma of B-cell type associated with the c-MYC immunoglobulin heavy chain fusion gene", J. Clin. Oncol. 18, 510–518.
   PubMed Web of Science ®Google Scholar
• Raghoebier, S., Kramer, M.H., van Krieken, J.H., de Jong, D., Limpens, J., Kluin-Nelemans, J.C., van Ommen, G.J. and Kluin, P.M. (1991) "Essential differencies in oncogene involvement between primary nodal and extranodal large cell lymphoma", Blood 78, 2680–2685.
   PubMed Web of Science ®Google Scholar
• Yano, T., Jaffe, ES., Longo, D.L. and Raffeld, M. (1992) "MYC rearrangements in histologically progressed follicular lymphomas", Blood 80, 758–767.
   PubMed Web of Science ®Google Scholar
• Dyomin, V.G., Palanisamy, N., Lloyd, K.O., Dyomina, K., Jhanwar, S.C., Houldsworth, J. and Chaganti, R.S. (2000) "MUC-1 is activated in a B-cell lymphoma by the t(1;14)(q21;q32) translocation and is rearranged and ampli-fied in B-cell lymphoma subsets", Blood 95, 2666–2671.
   PubMed Web of Science ®Google Scholar
• Gilles, F., Goy, A., Remache, Y., Shue, P. and Zelenetz, A.D. (2000) "MUC-1 dysregulation as the consequence of a t(1;14)(q21;q32) translocation in an extranodal lymphoma", Blood 95, 2930–2936.
   PubMed Web of Science ®Google Scholar
• Wesseling, J., van der Valk, S.W., Vos, H.L., Sonnenberg, A. and Hilkens, J. (1995) "Episialine (MUC-1) overexpression inhibits integrin mediated cell adhesion to extracellular matrix components", J. Cell. Biol. 129, 255–265.
   PubMed Web of Science ®Google Scholar
• Agrawal, B., Krantz, M.J., Reddish, M.A. and Longenecker, B.M. (1998) "Cancer associated MUC-1 mucin inhibits human T cell proliferation, which is reversible by IL2", Nat. Med. 4, 43–49.
   PubMed Web of Science ®Google Scholar
• Baruch, A., Hartmann, M., Yoeli, M., Adereth, Y., Green-stein, S., Stadler, Y., Skornik, Y, Zaretsky, J., Smorodinsky, N.J., Keydar, I. and Wreschner, D.H. (1999) "The breast cancer associated MUC-1 gene generates both a receptor and his cognate binding protein", Cancer. Res. 59, 1552–1561.
   PubMed Web of Science ®Google Scholar
• Kirsch, D.G. and Kastan, M.B. (1998) "Tumor-suppressor p53: implications for tumor development and prognosis", J. Clin. Oncol. 16, 3158–3168.
   PubMed Web of Science ®Google Scholar
• Ichikawa, A., Kinoshita, T., Watanabe, T., Kato, H., Nagai, H., Tsushita, K., Saito, H. and Hotta, T. (1997) "Mutations of the p53 gene as a prognostic factor in aggressive B-cell lymphoma", N. Engl. J. Med. 337, 529–534.
   PubMed Web of Science ®Google Scholar
• Koduru, P.R., Raju, K., Vadmal, V, Menezes, G., Shah, S., Susin, M., Kolitz, J. and Broome, J.D. (1997) "Correlation between mutation in P53, p53 expression, cytogenetics, histologic type, and survival in patients with B-cell non-Hodgkin's lymphoma", Blood 90, 4078–4091.
   PubMed Web of Science ®Google Scholar
• Pinyol, M., Cobo, F., Bea, S., Jares, E, Nayach, I., Fernandez, EL., Montserrat, E., Cardesa, A. and Campo, E. (1998) "p16INK4a gene inactivation by deletions, mutations and hypermethylation is associated with transformed and aggressive variants of non-Hodgkin lymphomas", Blood 91, 2977–2984.
   PubMed Web of Science ®Google Scholar
• Sherr, C.J. (2001) "The lNK4a/ARF network in tumour suppression", Nat. Rev. Mol. Cell Biol. 2, 731–737.
   PubMed Web of Science ®Google Scholar
• Serrano, M., Lee, H., Chin, L., Cordon-Cardo, C., Beach, D. and DePinho, R.A. (1996) "Role of the lNK4a locus in tumor suppression and cell mortality", Cell 85, 27–37.
   PubMed Web of Science ®Google Scholar
• Singal, R. and Ginder, G.D. (1999) "DNA methylation", Blood 93, 4059–4070.
   PubMed Web of Science ®Google Scholar
• Pegg, A.E. (2000) "Repair of 0(6)-alkylguanine by alkyl-transferases", Mutat. Res. 462, 83–100.
   PubMed Web of Science ®Google Scholar
• Esteller, M., Gaidano, G., Goodman, S.N., Zagonel, V, Capello, D., Botto, B., Rossi, D., Gloghini, A., Vitolo, U., Carbone, A., Baylin, S.B. and Herman, J.G. (2002) "Hyper-methylation of the DNA repair gene 06-methylguanine DNA methyltransferase and survival of patients with diffuse large B-cell lymphoma", J. Natl. Cancer Inst. 94, 26–32.
   PubMed Web of Science ®Google Scholar
• Esteller, M., Toyota, M., Sanchez-Cespedes, M., Capella, G., Peinado, M.A., Watkins, D.N., Issa, J.P., Sidransky, D., Baylin, S.B. and Herman, J.G. (2000) "Inactivation of the DNA repair gene 06-methylguanine-DNA methyltransfer-ase by promoter hypermethylation is associated with G to A mutations in K-ras in colorectal tumorigenesis", Cancer Res. 60, 2368–2371.
   PubMed Web of Science ®Google Scholar
• Sakumi, K., Shiraishi, A., Shimizu, S., Tsuzuki, T., Ishikawa, T. and Sekiguchi, M. (1997) "Methylnitrosourea-induced tumorigenesis in MGMT gene knockout mice", Cancer Res. 57, 2415–2418.
   PubMed Web of Science ®Google Scholar
• Mattern, J., Eichhorn, U., Kaina, B. and Volm, M. (1998) "06-methylguanine-DNA methyltransferase activity and sensi-tivity to cyclophosphamide and cisplatin in human lung tumor xenografts", Int. J. Cancer 77, 919–922.
   PubMed Web of Science ®Google Scholar
• Cai, Y, Wu, M.H., Ludeman, S.M., Grdina, D.J. and Dolan, M.E. (1999) "Role of 06-alkylguanine-DNA alkyltransferase in protecting against cyclophosphamide-induced toxicity and mutagenicity", Cancer Res. 59, 3059–3063.
   PubMed Web of Science ®Google Scholar
• Pasqualucci, L., Neumeister, P., Goossens, T., Nanjangud, G., Chaganti, R.S., Kappers, R. and Dalla-Favera, R. (2001) "Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas", Nature 412, 341–346.
   PubMed Web of Science ®Google Scholar
• A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. The Non-Hodgkin's Lymphoma Classification Project(1997), Blood 89, 3909–3918.
   PubMed Web of Science ®Google Scholar
• The International non-Hodgkin Lymphoma Prognostic Factor Proget: a predictive model for aggressive non-Hodgkin lymphoma (1993), N. Engl. J. Med. 329, 987–994.
   PubMed Web of Science ®Google Scholar
• Shipp, MA., Ross, K.N., Tamayo, P., Weng, A.P., Kutok, J.L., Aguiar, R.C., Gaasenbeek, M., Angelo, M., Reich, M., Pinkus, G.S., Ray, T.S., Koval, MA., Last, K.W., Norton, A., Lister, TA., Mesirov, J., Neuberg, D.S., Lander, ES., Aster, J.C. and Golub, T.R. (2002) "Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning", Nat. Med. 8, 68–74.
   PubMed Web of Science ®Google Scholar
• Lossos, IS., Alizadeh, A.A., Eisen, M.B., Chan, W.C., Brown, P.O., Botstein, D., Staudt, L.M. and Levy, R. (2000) "Ongoing immunoglobulin somatic mutations in germinal center B cell like but not in activated B cell like diffuse large cell lymphomas", Proc. Natl. Acad. Sci. USA 97, 10202–10213.
   Web of Science ®Google Scholar
• Huang, J.Z., Sanger, W.G., Greiner, T.C., Staudt, L.M., Weisenburger, D.D., Pickering, DL., Lynch, J.C., Armitage, JD., Warnke, R.A., Alizadeh, A.A., Lossos, IS., Levy, R. and Chan, W.C. (2002) "The t(14;18) defines a unique subset of diffuse large B-cell lymphoma with a germinal center B-cell gene expression profile", Blood 99, 2285–2290.
   PubMed Web of Science ®Google Scholar
• Ballerini, P., Gaidano, G., Gong, J.Z., Tassi, V, Saglio, G., Knowles, D.M. and Dalla-Favera, R. (1993) "Multiple genetic lesions in acquired immunodeficiency syndrome-related nonHodg,kin lymphoma", Blood 81, 166–176.
   PubMed Web of Science ®Google Scholar
• Carbone, A., Tirelli, U., Gloghini, A., Volpe, R. and Boiocchi, M. (1993) "Human immunodeficiency virus associated systemic lymphomas may be subdivided into two main groups according to Epstein-Barr viral latent gene expression", J. Clin. Oncol. 11, 1674–1681.
   PubMed Web of Science ®Google Scholar
• Hamilton-Dutoit, S.J., Rea, D., Raphael, M., Sandvej, K., Deleduse, H.J., Gisselbrecht, C., Marelle, L., van Krieken, H.J. and Pallesen, G. (1993) "Epstein-Barr virus-latent gene expression and tumor cell phenotype in acquired immunodeficiency syndrome-related non-Hodgkin's lym-phoma. Correlation of lymphoma phenotype with three distinct patterns of viral latency", Am. J. Pathol. 143, 1072–1085.
   PubMed Web of Science ®Google Scholar
• Kulwichit, W., Edwards, R.H., Davenport, EM., Baskar, J.F., Godfrey, V. and Raab-Traub, N. (1998) "Expression of the Epstein-Barr virus latent membrane protein 1 induces B cell lymphomas in transgenic mice", Proc. Natl. Acad. Sci. USA 95, 11963–11968.
   PubMed Web of Science ®Google Scholar
• Rothe, M., Sarma, V, Dixit, V.M. and Goeddel, D.V. (1995) "TRAF2 mediated activation of NF-kB by the TNF receptor 2 and CD40", Science 269, 1424–1427.
   PubMed Web of Science ®Google Scholar
• Henderson, S., Rowe, M., Gregory, C., Croom-Carter, D., Wang, E, Longnecker, R., Kieft E. and Rickinson, A. (1991) "Induction of BCL-2 expression by Epstein-Barr virus latent membrane protein-1 protects infected B cells from pro-grammed cell death", Cell 65, 1107–1115.
   PubMed Web of Science ®Google Scholar
• Kersten, M.J., Klein, MR., Holwerda, A.M., Miedema, F. and van Oers, M.H. (1997) "Epstein-Barr virus-specific cytotoxic T cell responses in 1-11V-1 infection: different kinetics in patients progressing to opportunistic infection or non-Hodgkin's lymphoma", J. Clin. Invest. 99, 1525–1533.
   PubMed Web of Science ®Google Scholar
• Gaidano, G., Lo Coco, E, Ye, B.H., Shibata, D., Levine, AM., Knowles, D.M. and Dalla-Favera, R. (1994) "Rearrangements of the BCL-6 gene in AIDS-associated non-Hodgkin lymphoma: association with diffuse large cell subtype", Blood 84, 397–402.
   PubMed Web of Science ®Google Scholar
• Gaidano, G., Pasqualucci, L., Vivenza, D., Deambrogi, C., Bertoncin, G., Berra, E., Capello, D., Rossi, D., Conconi, A., Gloghini, A., Saglio, G., Carbone, A. and Dalla-Favera, R. (2001) "Hypermutation of multiple proto-oncogenes in AIDS-related lymphoma", Blood 98, 503a.
   Web of Science ®Google Scholar
• Knowles, D.M., Cesarman, E., Chadburn, A., Frizzera, G., Chen, J., Rose, E.A. and Michler, RE. (1995) "Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of posttransplantation lymphopro-liferative disorders", Blood 85, 552–565.
   PubMed Web of Science ®Google Scholar
• Tanner, J.E. and Alfieri, C. (2001) "The Epstein-Barr virus and post-transplant lymphoproliferative disease: interplay of immunosuppression, EBV, and the immune system in disease pathogenesis", Transpl. Infect. Dis. 3, 60–69.
   PubMedGoogle Scholar
• Chadburn, A., Chen, J.M., Hsu, D.T., Frizzera, G., Cesarman, E., Garrett, T.J., Mears, J.G., Zangwill, S.D., Addonizio, L.J., Michler, RE. and Knowles, D.M. (1998) "The morphologic and molecular genetic categories of posttransplantation lymphoproliferative disorders are clinically relevant", Cancer 82, 1978–1987.
   PubMed Web of Science ®Google Scholar
• Nelson, B.P., Nalesnik, M.A., Bahler, D.W., Locker, J., Fung, J.J. and Swerdlow, S.H. (2000) "Epstein-Barr virus-negative post-transplant lymphoproliferative disorders: a distinct entity?", Am. J. Surg. Pat hol. 24, 375–385.
   PubMed Web of Science ®Google Scholar
• Deleduse, H.J., Rouault, J.P., Jeammot, B., Kremmer, E., Bastard, C. and Berger, F. (1995) "Bc16/Laz3 rearrangements in post-transplant lymphoproliferative disorders", Br. J. Haematol. 91, 101–103.
   PubMed Web of Science ®Google Scholar